Generic placeholder image

Current Organic Chemistry

Editor-in-Chief

ISSN (Print): 1385-2728
ISSN (Online): 1875-5348

Review Article

State-of-Art on the Synthesis of Heterocyclic Compounds Targeting SARS-CoV-2

In Press, (this is not the final "Version of Record"). Available online 25 September, 2024
Author(s): Pedro Alves Bezerra Morais*, Jéssica Adalgisa Barbosa Silva, Clara Lirian Javarini, Caroline de Souza Fontes Gaspari, Ramon Ramires Trancoso Bottocim, Thays Cardoso Valim, Carla Santana Francisco, Alvaro Cunha Neto and Valdemar Lacerda Júnior
Published on: 25 September, 2024

DOI: 10.2174/0113852728248762240812075831

Price: $95

conference banner
Abstract

The Corona Virus Disease-19 (COVID-19) pandemic challenged the scientific community in the search for developing effective treatments, such as medicine and/or a vaccine candidate. The SARS-CoV-2 virus and its variants, Omega, Omicron, and Delta, remain as a major threat to human health, causing significant morbidity and mortality worldwide. Given that computational methods are thought to be quick, easy, and inexpensive, they have been widely used in this scenario to design new anti-COVID-19 drug candidates. In addition, heterocyclic scaffolds have been explored exhaustively for their biological properties and as fruitful sources of new molecular entities to fulfill the chemical space available.In light of this, we intend to highlight the synthetic techniques used to produce novel heterocyclic derivatives that may serve as effective anti- COVID-19 lead candidates by focusing on important viral proteins and using computational tools. Then, the objective of this article, with a theoretical nature, is to contribute to the delimitation of organic chemistry methods to achieve new anti-COVID-19 agents.

Keywords: SARS-CoV-2, COVID-19, heterocyclic, lead compounds, drug discovery.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy